Clinical Research

Clinical Research. CNS actively collaborates with pharmaceutical and biotechnology clients to design, execute, and report on clinical research programs, with a primary dedication to diseases of the central nervous system. By combining full service operational and strategic capabilities with broad Phase 1 and therapeutic-area focused Phase 2 to 4 research centers within a single organization, CNS is uniquely positioned to provide rapid, definitive clinical answers, for small and large companies alike. Biopharmaceutical and contract research clients benefit from our organizational synergies and high-quality data when conducting advanced phase (Phase 2 to 4) programs. All clients gain from CNS expertise in producing the most scientifically rigorous yet practically feasible research programs across all development phases. CNS provides a unique turn-key solution for design, execution (including biostatistics and data management), interpretation and communication in Phase 1 and 2 development. This solution gives clients the ability to move compounds from first-in-human to proof of concept with a single provider.

Care Management Technologies. CNS provides public/government and private healthcare organizations with products and services that positively impact care for the chronically mentally ill in multiple outcome spheres. Based on the needs of our client organizations, these products and services can be applied to large populations, groups of individuals with a particular age or disease, or patients at elevated risk for poor outcome. Through technologic and methodological innovation, CNS routinely transforms critical insights into actionable solutions to improve care -- insights otherwise hidden in the massive organizational and governmental databases common in modern clinical research practice. By understanding the challenge of caring for individuals with serious and persistent mental illness in the context of an often disjointed and misaligned care-delivery system, CNS is uniquely positioned to bridge disparate treatment team professionals. CNS’ focus on the quality of prescribing, patient adherence to medication, and the common medical conditions carried by individuals with serious and persistent mental illness, provides clients the ability to improve patient outcomes while simultaneously reducing pharmacy and inpatient costs in parallel. Further, the assembly of a coordinated, evidence-based approach enables available clinical resources to be more efficiently and effectively applied to alleviate both the behavioral and medical disease burden these patients regularly encounter.

Educational Solutions. As a physician-led organization, CNS holds an inherent advantage in developing educational content and delivery which engages, challenges, and endures. With a core dedication to providing useful resolutions to clinical dilemmas, CNS Expert Knowledge Systems stands apart from currently available programs, which are often centered on generic, mass-produced subject matter. Ultimately, when behavioral healthcare professionals can easily access the combined historical and contemporary knowledge of hundreds of disease-specific experts, patient care is both enhanced. Further, CNS’ approaches permit the treatment team to adopt and adapt to the unending stream of new data on the pathology and treatment of brain-related illness.